ARTICLE | Company News
Morphotek, Eisai deal
March 26, 2007 7:00 AM UTC
Eisai bolstered its oncology portfolio last September by acquiring the cancer product line of Ligand Pharmaceuticals Inc. (LGND, San Diego, Calif.) (see BioCentury, Sept. 11, 2006). Eisai also has E...